Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme.
暂无分享,去创建一个
[1] J. Laragh,et al. Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. , 1972, The American journal of medicine.
[2] J. Laragh. Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. , 1973, The American journal of medicine.
[3] A. Barger,et al. The Role of the Renin‐Angiotensin‐Aldosterone System in Cardiovascular Homeostasis in Normal Human Subjects , 1976, Circulation.
[4] J. Laragh,et al. Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients. , 1976, The American journal of medicine.
[5] Y. S. Bakhle,et al. Conversion of Angiotensin I to Angiotensin II by Cell-free Extracts of Dog Lung , 1968, Nature.
[6] R. Tarazi,et al. Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations. , 1972, The American journal of cardiology.
[7] D. Streeten,et al. Use of an angiotensin II antagonist (saralasin) in the recognition of "angiotensinogenic" hypertension;. , 1975, The New England journal of medicine.
[8] J. Laragh,et al. Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension. , 1973, The American journal of cardiology.
[9] J. Laragh,et al. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin. , 1976, The American journal of medicine.
[10] J. Stewart,et al. Inactivation of bradykinin in the pulmonary circulation. , 1968 .
[11] J. Laragh,et al. Radioimmunoassay of plasma renin activity. , 1975, Seminars in nuclear medicine.
[12] B. Rubin,et al. Inhibition of Pressor Effects of Angiotensin I and Augmentation of Depressor Effects of Bradykinin by Synthetic Peptides 1 , 1972, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[13] J. Laragh,et al. Renovascular hypertension: renin measurements to indicate hypersecretion and contralateral suppression, estimate renal plasma flow, and score for surgical curability. , 1973, The American journal of medicine.
[14] Y. S. Bakhle,et al. Inhibition of angiotensin I converting enzyme by venom peptides , 1971, British journal of pharmacology.
[15] M. Maxwell,et al. Saralasin bolus test Rapid screening procedure for renin-mediated hypertension , 1975, The Lancet.
[16] E. G. Erdös,et al. Angiotensin I converting enzyme. , 1975, Circulation research.
[17] G. Kelliher,et al. Central hypotensive activity of dl- and d-propranolol. , 1970, Journal of pharmaceutical sciences.
[18] A. Barger,et al. Inhibition of angiotensin conversion and prevention of renal hypertension. , 1975, The American journal of physiology.
[19] J. Laragh,et al. Specific inhibition of the renin-angiotensin system: A key to understanding blood pressure regulation. , 1974, Progress in cardiovascular diseases.
[20] R. Colman,et al. Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture. , 1975, The Journal of clinical investigation.
[21] D. Adams,et al. Blockade and stimulation of renal, adrenal, and vascular angiotensin II receptors with 1-Sar, 8-Ala angiotensin II in normal man. , 1976, The Journal of clinical investigation.
[22] D. B. Evans,et al. Inhibition by SQ 20881 of vasopressor response to angiotensin I in conscious animals. , 1973, European journal of pharmacology.
[23] H. Gavras,et al. Reciprocal relation between renin dependency and sodium dependency in essential hypertension. , 1976, The New England journal of medicine.